DE69031726D1 - Antikörper, ihre Herstellung und Verwendung - Google Patents

Antikörper, ihre Herstellung und Verwendung

Info

Publication number
DE69031726D1
DE69031726D1 DE69031726T DE69031726T DE69031726D1 DE 69031726 D1 DE69031726 D1 DE 69031726D1 DE 69031726 T DE69031726 T DE 69031726T DE 69031726 T DE69031726 T DE 69031726T DE 69031726 D1 DE69031726 D1 DE 69031726D1
Authority
DE
Germany
Prior art keywords
polypeptide
antibody
formula
acid sequence
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69031726T
Other languages
English (en)
Other versions
DE69031726T2 (de
Inventor
Kazuo Nakahama
Tsunehiko Fukuda
Tsutomu Kurokawa
Ken-Ichi Kuroshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69031726D1 publication Critical patent/DE69031726D1/de
Publication of DE69031726T2 publication Critical patent/DE69031726T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C07K14/625—Extraction from natural sources
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69031726T 1989-08-28 1990-08-24 Antikörper, ihre Herstellung und Verwendung Expired - Lifetime DE69031726T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21871189 1989-08-28
JP13405890 1990-05-25

Publications (2)

Publication Number Publication Date
DE69031726D1 true DE69031726D1 (de) 1998-01-02
DE69031726T2 DE69031726T2 (de) 1998-03-12

Family

ID=26468244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69031726T Expired - Lifetime DE69031726T2 (de) 1989-08-28 1990-08-24 Antikörper, ihre Herstellung und Verwendung

Country Status (7)

Country Link
EP (1) EP0418590B1 (de)
AT (1) ATE160288T1 (de)
CA (1) CA2024063C (de)
DE (1) DE69031726T2 (de)
DK (1) DK0418590T3 (de)
ES (1) ES2109225T3 (de)
GR (1) GR3025835T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
KR101410692B1 (ko) 2002-12-24 2014-06-24 리나트 뉴로사이언스 코프. 항-ｎｇｆ 항체 및 그것을 이용하는 방법
EP2191846A1 (de) 2003-02-19 2010-06-02 Rinat Neuroscience Corp. Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor-antagonisten und eines nsaid und diese enthaltende zusammensetzung
ME02785B (me) 2003-07-15 2012-12-31 Amgen Inc Humana anti-ngf neutrališuća antitela kao selektivni inhibitori ngf signalnog puta
PT2206728T (pt) 2004-04-07 2018-04-17 Rinat Neuroscience Corp Métodos de tratamento da dor associada ao cancro ósseo através da administração de um anticorpo antagonista do fator de crescimento nervoso
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
WO2010079850A2 (en) 2009-01-12 2010-07-15 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of cancer

Also Published As

Publication number Publication date
JPH04128298A (ja) 1992-04-28
EP0418590B1 (de) 1997-11-19
ATE160288T1 (de) 1997-12-15
GR3025835T3 (en) 1998-04-30
EP0418590A1 (de) 1991-03-27
DE69031726T2 (de) 1998-03-12
ES2109225T3 (es) 1998-01-16
DK0418590T3 (da) 1998-04-20
CA2024063C (en) 2002-07-16
CA2024063A1 (en) 1991-03-01

Similar Documents

Publication Publication Date Title
Giri et al. Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
LU91013I2 (fr) ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base
ATE155141T1 (de) Glykosphingolipide mit kopplungsfähiger gruppe im sphingoidanteil, ihre herstellung und verwendung
AU564620B2 (en) Peptides and protein-peptide complexes
ATE160288T1 (de) Antikörper, ihre herstellung und verwendung
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
EP0741869A1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO900758D0 (no) Fremgangsmaate for fremstilling av hybridprotein.
ATE221082T1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä- b zellen und sein gen
NO871573L (no) Fremgangsmaate for fremstilling av peptider.
DE3781832D1 (de) C-terminal-alpha-amidierendes enzym und verfahren zu dessen herstellung und verwendung.
DK0404750T3 (da) Vævsinhibitor for metalloproteaser
Yanaihara et al. Synthesis of proinsulin. III. Synthesis of polypeptides related to the connecting peptide segment of bovine proinsulin
NO904129D0 (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP